Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$23.0 - $31.04 $1.79 Million - $2.42 Million
-78,000 Reduced 38.39%
125,174 $3.17 Million
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $1.95 Million - $2.89 Million
71,421 Added 54.21%
203,174 $6.28 Million
Q4 2023

Feb 13, 2024

SELL
$24.02 - $43.89 $2.19 Million - $4 Million
-91,194 Reduced 40.9%
131,753 $5.32 Million
Q3 2023

Nov 14, 2023

BUY
$16.89 - $35.01 $3.77 Million - $7.81 Million
222,947 New
222,947 $5.88 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.08B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.